New York, February 17, 2016 -- Moody's Investors Service today assigned a Ba2 (LGD 2) rating to Select Medical Corporation's proposed $625 million term loan due 2021. Select Medical Corporation is a wholly owned subsidiary of Select Medical Holdings Corporation (collectively Select). Select's other ratings, including its B1 Corporate Family Rating and B1-PD Probability of Default Rating are unchanged. The stable rating outlook is also unchanged.

Vollständigen Artikel bei Moodys lesen